171 related articles for article (PubMed ID: 32008156)
1. Low bone mineral density is associated with hypogonadism and cranial irradiation in male childhood cancer survivors.
Isaksson S; Bogefors K; Åkesson K; Øra I; Egund L; Bobjer J; Leijonhufvud I; Giwercman A
Osteoporos Int; 2020 Jul; 31(7):1261-1272. PubMed ID: 32008156
[TBL] [Abstract][Full Text] [Related]
2. Risk of low bone mineral density in testicular germ cell cancer survivors: association with hypogonadism and treatment modality.
Isaksson S; Bogefors K; Åkesson K; Egund L; Bobjer J; Leijonhufvud I; Giwercman A
Andrology; 2017 Sep; 5(5):898-904. PubMed ID: 28591464
[TBL] [Abstract][Full Text] [Related]
3. Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study.
van Atteveld JE; de Winter DTC; Pluimakers VG; Fiocco M; Nievelstein RAJ; Hobbelink MGG; de Vries ACH; Loonen JJ; van Dulmen-den Broeder E; van der Pal HJ; Pluijm SMF; Kremer LCM; Ronckers CM; van der Heiden-van der Loo M; Versluijs AB; Louwerens M; Bresters D; van Santen HM; Olsson DS; Hoefer I; van den Berg SAA; den Hartogh J; Tissing WJE; Neggers SJCMM; van den Heuvel-Eibrink MM;
Lancet Diabetes Endocrinol; 2023 Jan; 11(1):21-32. PubMed ID: 36513116
[TBL] [Abstract][Full Text] [Related]
4. Bone density in post-pubertal adolescent survivors of childhood brain tumors.
Cohen LE; Gordon JH; Popovsky EY; Sainath NN; Feldman HA; Kieran MW; Gordon CM
Pediatr Blood Cancer; 2012 Jun; 58(6):959-63. PubMed ID: 22431246
[TBL] [Abstract][Full Text] [Related]
5. High risk of hypogonadism in young male cancer survivors.
Isaksson S; Bogefors K; Ståhl O; Eberhard J; Giwercman YL; Leijonhufvud I; Link K; Øra I; Romerius P; Bobjer J; Giwercman A
Clin Endocrinol (Oxf); 2018 Mar; 88(3):432-441. PubMed ID: 29245176
[TBL] [Abstract][Full Text] [Related]
6. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
[TBL] [Abstract][Full Text] [Related]
7. A long-term trajectory of bone mineral density in childhood cancer survivors after discontinuation of treatment: retrospective cohort study.
Latoch E; Konstantynowicz J; Krawczuk-Rybak M; Panasiuk A; Muszyńska-Rosłan K
Arch Osteoporos; 2021 Feb; 16(1):45. PubMed ID: 33635381
[TBL] [Abstract][Full Text] [Related]
8. Increased Bone Mineral Density in Male Patients With Idiopathic Hypogonadotropic Hypogonadism Who Undergo Sex Hormone Therapy: Findings From Cross-Sectional and Longitudinal Studies.
Zhang R; Mao J; Wang X; Nie M; Ma W; Ji W; Yu B; Huang Q; Wu X
Endocr Pract; 2021 Sep; 27(9):934-940. PubMed ID: 34000389
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of hypogonadism and associated impaired metabolic and bone mineral status in subfertile men.
Bobjer J; Bogefors K; Isaksson S; Leijonhufvud I; Åkesson K; Giwercman YL; Giwercman A
Clin Endocrinol (Oxf); 2016 Aug; 85(2):189-95. PubMed ID: 26857217
[TBL] [Abstract][Full Text] [Related]
10. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer.
den Hoed MA; Klap BC; te Winkel ML; Pieters R; van Waas M; Neggers SJ; Boot AM; Blijdorp K; van Dorp W; Pluijm SM; van den Heuvel-Eibrink MM
Osteoporos Int; 2015 Feb; 26(2):521-9. PubMed ID: 25209410
[TBL] [Abstract][Full Text] [Related]
12. Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral density.
Lubushitzky R; Front D; Iosilevsky G; Bettman L; Frenkel A; Kolodny GM; Israel O
J Nucl Med; 1998 Jan; 39(1):104-7. PubMed ID: 9443746
[TBL] [Abstract][Full Text] [Related]
13. Osteopenia in young adult survivors of childhood cancer.
Vassilopoulou-Sellin R; Brosnan P; Delpassand A; Zietz H; Klein MJ; Jaffe N
Med Pediatr Oncol; 1999 Apr; 32(4):272-8. PubMed ID: 10102021
[TBL] [Abstract][Full Text] [Related]
14. Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study.
Chemaitilly W; Li Z; Huang S; Ness KK; Clark KL; Green DM; Barnes N; Armstrong GT; Krasin MJ; Srivastava DK; Pui CH; Merchant TE; Kun LE; Gajjar A; Hudson MM; Robison LL; Sklar CA
J Clin Oncol; 2015 Feb; 33(5):492-500. PubMed ID: 25559807
[TBL] [Abstract][Full Text] [Related]
15. Modifiable risk factors associated with bone deficits in childhood cancer survivors.
Polgreen LE; Petryk A; Dietz AC; Sinaiko AR; Leisenring W; Goodman P; Steffen LM; Perkins JL; Dengel DR; Baker KS; Steinberger J
BMC Pediatr; 2012 Mar; 12():40. PubMed ID: 22455440
[TBL] [Abstract][Full Text] [Related]
16. Hypogonadism risk in men treated for childhood cancer.
Romerius P; Ståhl O; Moëll C; Relander T; Cavallin-Ståhl E; Wiebe T; Giwercman YL; Giwercman A
J Clin Endocrinol Metab; 2009 Nov; 94(11):4180-6. PubMed ID: 19789207
[TBL] [Abstract][Full Text] [Related]
17. Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors.
Ekedahl H; Isaksson S; Ståhl O; Bogefors K; Romerius P; Eberhard J; Giwercman A
BMC Cancer; 2022 Feb; 22(1):157. PubMed ID: 35135482
[TBL] [Abstract][Full Text] [Related]
18. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
Antonio L; Caerels S; Jardi F; Delaunay E; Vanderschueren D
Andrology; 2019 May; 7(3):302-306. PubMed ID: 30851011
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Low and Very Low Bone Mineral Density Among Adult Survivors of Childhood Cancer.
van Atteveld JE; Pluijm SMF; Ness KK; Hudson MM; Chemaitilly W; Kaste SC; Robison LL; Neggers SJCMM; Yasui Y; van den Heuvel-Eibrink MM; Wilson CL
J Clin Oncol; 2019 Sep; 37(25):2217-2225. PubMed ID: 31169453
[TBL] [Abstract][Full Text] [Related]
20. Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors - results from a randomized double-blind trial.
Jørgensen PL; Kreiberg M; Jørgensen N; Juul A; Oturai PS; Dehlendorff C; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Medici CR; Jørgensen NR; Bandak M
Acta Oncol; 2023 Jul; 62(7):689-695. PubMed ID: 37151105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
